A recent Interesting Engineering article contained good news in the fight against the HIV epidemic. Last Monday, the FDA announced its approval of the first injectable medication for pre-exposure prevention (aka PrEP) against HIV. The drug is called Apretude, and it was developed by ViiV Healthcare, which is majority-owned by GlaxoSmithKline. It is comparable to other HIV prevention pills such as Truvada and Descovy, which reduce HIV transmission risk by 99% when taken daily.
FDA Approves First HIV Prevention Shot
The drug is intended to reduce the risk of HIV transmission via intercourse, and replace ingestible alternatives.
Dec 28, 2021
Break out of the ordinary: see what’s new in life sciences packaging
At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us this month to experience a breakthrough for life sciences products.
REGISTER NOW!
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
